C4 Therapeutics
CCCC
#8153
Rank
โ‚น30.17 B
Marketcap
โ‚น229.80
Share price
1.64%
Change (1 day)
5.12%
Change (1 year)

EPS for C4 Therapeutics (CCCC)

EPS in 2026 (TTM): -โ‚น67.29

According to C4 Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น66.72. In 2025 the company made an earnings per share (EPS) of -โ‚น126.02 an increase over its 2024 EPS that were of -โ‚น139.92.

EPS history for C4 Therapeutics from 2024 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น67.29-46.6%
2025-โ‚น126.02-9.93%
2024-โ‚น139.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น125.09 87.50%๐Ÿ‡บ๐Ÿ‡ธ USA